Intangible Assets Give Quintiles IMS a Wide Moat
October 12, 2016 at 08:00 AM EDT
The merger between the medical clinical trial companies has created some upside for the stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.